Is Methylsulfonylmethane Joint Function Randomized Trial safe?

Updated October 2026

Quick Answer

Methylsulfonylmethane Joint Function Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: A combination of two or more supplements is common in clinical practice; however, evidence for the efficacy of this approach is lacking.

Key Takeaways

  • 01A combination of two or more supplements is common in clinical practice; however, evidence for the efficacy of this approach is lacking. [Liu X (2020)]
  • 02Introduction Hand osteoarthritis (HOA) is a highly prevalent disabling joint disease. [Liu X (2020)]
  • 03Potentially as a consequence, many people turn to complementary and alternative medicines for symptomatic relief. [Liu X (2020)]
The current Migaku evidence database contains 1 reusable source document for Methylsulfonylmethane Joint Function Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - A combination of two or more supplements is common in clinical practice; however, evidence for the efficacy of this approach is lacking. [Liu X (2020); evidence level 2] - Introduction Hand osteoarthritis (HOA) is a highly prevalent disabling joint disease. [Liu X (2020); evidence level 2] - Potentially as a consequence, many people turn to complementary and alternative medicines for symptomatic relief. [Liu X (2020); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Efficacy and safety of a supplement combination for hand osteoarthritis pain: protocol for an internet-based randomised placebo-controlled trial (The RADIANT study).